Compare Smurfit WestRock plc Ordinary Shares (SW) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smurfit WestRock plc Ordinary Shares vs GeneDx Holdings Corp — how do they compare? Smurfit WestRock plc Ordinary Shares trades at $41.29 (market cap $21.74B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Smurfit WestRock plc Ordinary Shares is far larger — about 10.8× GeneDx Holdings Corp's market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.36% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smurfit WestRock plc Ordinary Shares for 0 Days and GeneDx Holdings Corp for 19 Days on average.
| SW | WGS | |
|---|---|---|
Market Cap | $21.74B | $2.02B |
Volume | 5,178,763 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $51.84 | $167.51 |
52-Week Low | $32.79 | $34.51 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $35.23B | $2.05B |
Dividend Yield | 4.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx (WGS) trades at $67.73, down 1.17% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations, and returned to adjusted profitability early. However, 2026 fundamentals show concerning trends with a net loss of $106 million and negative profit margins. Recent news highlights product innovations and leadership recognition, while technical analysis indicates the stock is trading near key support at $66.
The investment outlook presents a dichotomy between strong analyst conviction (90.9% buy ratings, $81 consensus target) and challenging fundamentals. While operational improvements and genomic testing growth offer potential upside, persistent losses and negative cash flow trends create significant execution risk. The stock's current position near support levels combined with oversold RSI readings suggests potential for near-term bounce, but sustainable gains require meaningful profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Smurfit WestRock plc Ordinary Shares
Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.
Read more on SW →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
